13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001582384
Total reported value
$228.5M
$228.5M
7 檔
88.7%
According to the latest 13F quarterly dataset, Wildcat Capital Management, LLC managed an equity portfolio of $228.5M at the end of Q3 2024, spanning 7 distinct U.S. exchange-listed positions.
In Q3 2024, Wildcat Capital Management, LLC adopted a defensive or profit-taking posture, trimming 0 positions and completely liquidating 10 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ULCC | Frontier Group Holdings Inc | Stock-Other | 73.37% | +3.84% | — | |
| 2 | RLX | Rlx Technology Inc-adr | Stock-Other | 15.96% | — | — | |
| 3 | ALLO | Allogene Therapeutics Inc | Stock-Other | 4.00% | -4.05% | — | |
| 4 | URGN | UroGen Pharma Ltd. | Stock-Other | 3.08% | — | — | |
| 5 | ✓ | Skillz Inc | Stock-Other | 2.69% | — | — | |
| 6 | KRON1USD | Kronos Bio Inc | Stock-Other | 0.63% | — | — | |
| 7 | ✓ | Silexion Therapeutics CORP | Stock-Other | 0.26% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ULCC | Frontier Group Holdings Inc | +39.5% | — | Unchanged |
| 2 | RLX | Rlx Technology Inc-adr | +7.8% | — | Unchanged |
| 3 | ALLO | Allogene Therapeutics Inc | +2.3% | — | Unchanged |
| 4 | URGN | UroGen Pharma Ltd. | +1% | — | Unchanged |
| 5 | ✓ | Skillz Inc | +1% | — | Unchanged |
| 6 | ✓ | Silexion Therapeutics CORP | +0.3% | NEW | New buy |
| 7 | KRON1USD | Kronos Bio Inc | +0.2% | — | Unchanged |
| 8 | ✓ | Akili, Inc. | -0.1% | EXIT | Sold out |
| 9 | PCOR | Procore Technologies Inc | -0.2% | EXIT | Sold out |
| 10 | HLT | Hilton Worldwide Holdings In | -1.9% | EXIT | Sold out |
| 11 | FLUT | Flutter Entertainment plc | -1.9% | EXIT | Sold out |
| 12 | DASH | Doordash Inc - A | -7.2% | EXIT | Sold out |
| 13 | GSHD | Goosehead Insurance Inc -a | -7.3% | EXIT | Sold out |
| 14 | GLBE | Global-E Online Ltd. | -8% | EXIT | Sold out |
| 15 | MSFT | Microsoft CORP | -8.2% | EXIT | Sold out |
| 16 | MCO | Moody's CORP | -8.5% | EXIT | Sold out |
| 17 | FYBR | Frontier Communications Pare | -9.1% | EXIT | Sold out |
According to official SEC Form 13F filings, Wildcat Capital Management, LLC reported a total U.S. public equity portfolio value of $228.5M across 7 disclosed positions in Q3 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ULCC, RLX, ALLO) accounted for 88.7% of total reported equity market value during Q3 2024.
Top New Position Initiated
SILEXION THERAPEUTICS CORP
市值: $535.9K
Top Position Liquidated / Trimmed
FYBR
前期市值: $37.0M
During Q3 2024, Wildcat Capital Management, LLC's top holdings by market value included ULCC (73.4%)、RLX (16.0%)、ALLO (4.0%). The largest single position, ULCC, represented 73.4% of total portfolio value.
In Q3 2024, Wildcat Capital Management, LLC made 11 total portfolio adjustments, initiating 1 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 10 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.